This section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Article contentBridge loan strengthens Realbotix’s working capital position while the parties advance the proposed merger.

Sign In or Create an Account

or View more offersArticle content

LAS VEGAS — Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in humanoid robotics and embodied AI, announces that its wholly owned subsidiary, Realbotix LLC, has entered into a loan agreement with Onconetix, Inc. (“Onconetix”) for an unsecured bridge loan facility in connection with the proposed merger transaction involving Realbotix LLC and Onconetix previously announced on February 12, 2026.

Article contentWe apologize, but this video has failed to load.Try refreshing your browser, or
tap here to see other videos from our team.Article content

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

The bridge loan provides transaction-aligned working capital to Realbotix LLC while the parties advance the merger.

Article contentArticle contentKey TermsArticle content

  • Onconetix is the lender, Realbotix LLC is the borrower, and Realbotix Corp. provides a guarantee of payment under the note.
  • The facility consists of an unsecured promissory note with an initial draw of US$2,500,000 and additional draws available up to an aggregate amount of US$5,000,000.
  • The note is non-interest bearing. At closing of the merger, the note and all obligations under the loan documents will be automatically cancelled and discharged in full, without payment by Realbotix LLC or Realbotix Corp.
  • If the merger agreement is terminated, interest accrues on the outstanding principal amount at 12% per annum from the date of termination.

Article content

“The loan provides working capital for Realbotix LLC during the merger process, and preserves the economic alignment between Realbotix and Onconetix,” said Andrew Kiguel, CEO of Realbotix.

Article content

The loan agreement contains customary limited representations and warranties, limited events of default, and a negative covenant restricting Realbotix LLC and Realbotix Corp. from incurring, assuming, guaranteeing, or otherwise becoming liable for additional indebtedness without Onconetix’s prior written consent. The loan is unsecured and does not require any security interest, lien, pledge, collateral assignment, UCC filing, or other collateral arrangement.

Article contentAbout Realbotix Article content
Article content

Realbotix Corp. is a U.S. based innovator of humanoid robots and embodied AI systems designed for natural human interaction. Manufactured in the United States, Realbotix’s patented technologies enable lifelike facial expressions, fluid movement, vision systems, and advanced social engagement. The Company’s platforms are developed for applications in healthcare, education, service industries, and consumer markets. For more information, visit

Article contentwww.realbotix.aiArticle content

.

Article contentRealbotix.comArticle content

: Product site

Article content
Article contentRealbotix.AIArticle content

: Corporate and Investor site

Article content

Keep up-to-date on Realbotix developments by joining our online communities on Twitter, LinkedIn, and YouTube.

Article content

Follow Aria, our humanoid robot, on X, Instagram, and TikTok.

Article contentForward-Looking Statements Article content
Article content

This news release contains forward-looking statements and information within the meaning of applicable securities laws, including management’s objectives, strategies, beliefs, and intentions. Forward-looking statements are often, but not always, identified by words such as “may,” “will,” “plan,” “expect,” “anticipate,” “estimate,” “intend,” “believe,” or similar expressions referring to future events or results.

Article content

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

These forward-looking statements are based on management’s current opinions and expectations and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from those expressed or implied by such statements.

Article content

Readers are cautioned not to place undue reliance on forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

Article content

All forward-looking statements are subject to the risks and uncertainties detailed in the Company’s continuous disclosure filings available at www.sedarplus.ca. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

Article content

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Article contentArticle contentArticle contentArticle contentView source version on businesswire.com: Article content

https://www.businesswire.com/news/home/20260914451410/en/

Article contentArticle content

Contacts

Article content

Andrew Kiguel, CEO
[email protected]
[email protected]
[email protected]
Telephone: 647-578-7490

Article content